Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Miller Mary sold 294 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Oct 5, 2026 · Filed Oct 7, 2026

On Oct 5, 2026, Miller Mary (Chief Legal Officer) sold 294 Acrivon Therapeutics, Inc. shares at US$1.99 for US$585, leaving 81,715 shares. Filed Oct 7, 2026 (Form 4).

Sold
294 shares
Price
US$1.99
Value
US$585
Holding after
81,715 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockSale294US$1.9981,715Direct

Source

View original at SEC

Related